Profiel
Yiteng Liu is currently Chief Operating Officer & Executive Director at Antengene Corporation Co., Ltd. since 2017 and Chief Operating Officer at Antengene Corp.
Ltd. since 2021.
Formerly, Mr. Liu was Manager at CBRE Group, Inc. from 2011 to 2012.
Education includes a graduate degree from The Hong Kong University of Science & Technology in 2010 and an undergraduate degree from Harbin Institute of Technology in 2007.
Actieve functies van Yiteng Liu
| Bedrijven | Functie | Begin |
|---|---|---|
| ANTENGENE CORPORATION LIMITED | Operationeel Directeur | 02-11-2018 |
Antengene Corporation Co., Ltd.
Antengene Corporation Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Operationeel Directeur | 01-06-2017 |
Eerdere bekende functies van Yiteng Liu
| Bedrijven | Functie | Einde |
|---|---|---|
| CBRE GROUP, INC. | Corporate Officer/Principal | 01-05-2012 |
Opleiding van Yiteng Liu
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
CBRE Group, Inc.
CBRE Group, Inc. Real Estate DevelopmentFinance Provides global workspace solutions, advisory services and real estate investment services | Finance |
The Hong Kong University of Science & Technology
The Hong Kong University of Science & Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harbin Institute of Technology
Harbin Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Antengene Corporation Co., Ltd.
Antengene Corporation Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Antengene Corp. Ltd.
Antengene Corp. Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes hematologic malignancies therapies | Health Technology |
















